Ozmosi | IC-51 Drug Profile
Drug Search Results
Using advanced filters...
Advanced Search [+]

IC-51

Alternative Names: ic-51, ic51, ic 51
Clinical Status: Inactive
Latest Update: 2016-06-02
Latest Update Note: Clinical Trial Update

Product Description

Japanese Encephalitis purified inactivated vaccine (Sourced from: https://clinicaltrials.gov/ct2/show/NCT00604708)

Mechanisms of Action: Vaccine

Novel Mechanism: No

Modality: Vaccine

Route of Administration: Intramuscular

FDA Designation: *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Intercell USA
Company Location:
Company CEO:
Additional Commercial Interests: None

Clinical Description

Countries in Clinic:

Active Clinical Trial Count:

Recent & Upcoming Milestones

Highest Development Phases

Phase 4: Encephalitis, Japanese

Phase 3: Encephalitis, Japanese|Healthy Volunteers|Encephalitis, Viral|Encephalomyelitis

Trial ID

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Latest Trial Update Date

Data Updated

ACTRN12620000968976p

2006-7041-83/hah

N/A

Not yet recruiting

Pregnancy Outcomes|Diabetes Complications|Diabetes, Gestational

2021-12-14

ACTRN12616001604493p

ND01

N/A

Not yet recruiting

Tobacco Use Disorder

2019-09-02

2010-022265-10

2010-022265-10

P3

Completed

Encephalitis, Japanese

2014-10-01

2025-07-06

Primary Completion Date|Start Date|Study Completion Date|Treatments

2009-015595-10

2009-015595-10

P3

Completed

Encephalitis, Japanese

2013-08-09

2022-03-13

Treatments

NCT01047839

IC51-322

P3

Completed

Encephalitis, Japanese

2013-08-01

2019-03-19

Treatments

2009-015588-15

2009-015588-15

P3

Completed

Encephalitis, Japanese

2013-04-16

2025-06-28

Primary Completion Date|Start Date|Study Completion Date|Treatments|Trial Status

NCT01246479

IC51-324

P3

Completed

Encephalitis, Japanese

2012-10-01

2019-03-19

Treatments

NCT01041573

IC51-323

P3

Completed

Encephalitis, Japanese

2011-02-01

2019-03-19

Treatments

2008-004634-24

2008-004634-24

P3

Completed

Encephalitis, Japanese

2010-10-31

2022-03-12

Treatments

NCT00776230

IC51-314

P3

Completed

Encephalitis, Japanese

2010-06-01

2019-03-18

Treatments

NCT00595309

IC51-311

P3

Completed

Encephalitis, Japanese

2009-10-01

2019-03-18

Treatments

2007-002793-64

2007-002793-64

P3

Completed

Encephalitis, Japanese

2009-02-16

2022-03-12

Treatments

2007-002771-14

2007-002771-14

P3

Completed

Encephalitis, Japanese

2008-02-25

2022-03-12

Treatments

2005-000593-41

2005-000593-41

P3

Completed

Encephalitis, Japanese

2007-11-26

2022-03-12

Treatments

NCT00595270

IC51-305

P3

Completed

Encephalitis, Japanese

2007-09-01

2019-03-22

Treatments

2006-002076-18

2006-002076-18

P3

Completed

Encephalitis, Japanese

2007-04-20

2022-03-12

Treatments

NCT00594958

IC51-309

P3

Completed

Encephalitis, Japanese

2007-04-01

2019-03-22

Treatments

2005-003526-25

2005-003526-25

P3

Completed

Healthy Volunteers

2006-10-13

2022-03-12

Treatments

NCT00604708

IC51-301

P3

Completed

Encephalitis, Japanese

2006-09-01

2019-03-18

Treatments

NCT00596271

IC51-308

P3

Completed

Encephalitis, Japanese

2006-07-01

2019-03-18

2005-000100-14

IC51- 302

P3

Completed

Encephalitis, Japanese|Encephalitis, Viral

2006-05-08

2022-03-12

2004-002474-36

IC51-301

P3

Completed

Encephalitis, Viral|Encephalitis, Japanese

2006-03-17

2022-03-12

Treatments

2004-005072-17

2004-005072-17

P3

Completed

Encephalitis, Japanese

2006-02-06

2022-03-12

Treatments

NCT00595790

IC51-304

P3

Completed

Encephalitis, Japanese

2006-02-01

2019-03-22

2010-018630-52

IC51-315

P4

Completed

Encephalitis, Japanese

2011-10-11

2022-03-13

Treatments

Recent News Events

Date

Type

Title